Mankind Pharma has disclosed an acquisition to NSE, marking another expansion move. Details on the target and deal terms remain awaited by market participants.
Mankind Pharma has filed a BSE intimation about a stake acquisition by its wholly owned subsidiary. Details on the target and deal value remain undisclosed in the announcement.
Acquisition Mankind Pharma Limited has informed the Exchange about Acquisition Mankind Pharma Limited has informed the Exchange about Acquisition
Acquisition Mankind Pharma Limited has informed the Exchange about Acquisition Mankind Pharma Limited has informed the Exchange about Acquisition
Company Update Please find attached Intimation regarding acquisition of stake by a wholly owned subsidiary company. Please find attached Intimation regarding acquisition of stake by a wholly owned subsidiary company.
Company Update Please find attached Intimation regarding acquisition of stake by a wholly owned subsidiary company. Please find attached Intimation regarding acquisition of stake by a wholly owned subsidiary company.
Mankind Pharma Q3 FY25 Results
Mankind Pharma Q2 FY25 Results
NSE & BSE filings, quarterly results, insider trades, and smart volume alerts — delivered on WhatsApp or Telegram. No separate app to install.
"ZTOX alerts helped me catch a multi-bagger stock last quarter. The insider deals notifications are absolutely game-changing for retail investors."
No credit card required. Connect WhatsApp or Telegram in minutes.